Tonix Pharmaceuticals (TNXP) stock jumped 11% Friday after the company issued a business update along with a preliminary 2024 ...

Tonix Pharmaceuticals (TNXP) stock plunged after the company carried out a 1-for-100 reverse stock split as it awaits approval for its breakthrough fibromyalgia treatment. Leverage the power of ...

Research analysts at StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” ...

Tonix Pharmaceuticals (TNXP) announced that it will effect a 1-for-100 reverse stock split of its outstanding common stock. The reverse stock ...

Tonix Pharmaceuticals (NASDAQ: TNXP) will implement a 1-for-100 reverse stock split, effective at <a target=_blank href= ...

Tonix’s common stock will continue to trade on the NASDAQ Capital Market under the symbol “TNXP” and under a new CUSIP number, 890260839. As a result of the reverse stock split, every one ...

The stock has a market capitalization of $71.60 million, a P/E ratio of -0.01 and a beta of 2.02. Get Tonix Pharmaceuticals alerts: Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report ...